Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

Portal:COVID-19

●العربية ●বাংলা ●Deutsch ●Español ●Français ●Bahasa Indonesia ●Bahasa Melayu ●Oʻzbekcha / ўзбекча ●Português ●සිංහල ●سنڌي ●اردو ●Tiếng Việt ●粵語 ●中文 Edit links ●Portal ●Talk ●Read ●View source ●View history Tools Actions ●Read ●View source ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version In other projects ●Wikisource

From Wikipedia, the free encyclopedia

Portal topics

The COVID-19 portal

Shortcut

P:COVID-19

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. Most scientists believe the SARS-CoV-2 virus entered into human populations through natural zoonosis, similar to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Social and environmental factors including climate change, natural ecosystem destruction and wildlife trade increased the likelihood of such zoonotic spillover. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

Transmission and life-cycle of SARS-CoV-2 causing COVID-19.

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

The pandemic caused severe social and economic disruption around the world, including the largest global recession since the Great Depression. Widespread supply shortages, including food shortages, were caused by supply chain disruptions and panic buying. Reduced human activity led to an unprecedented temporary decrease in pollution. Educational institutions and public areas were partially or fully closed in many jurisdictions, and many events were cancelled or postponed during 2020 and 2021. Telework became much more common for white-collar workers as the pandemic evolved. Misinformation circulated through social media and mass media, and political tensions intensified. The pandemic raised issues of racial and geographic discrimination, health equity, and the balance between public health imperatives and individual rights. (Full article)

Pandemic

Virus

Disease

About the virus

SARS-CoV-2 as seen by a cryo-electron tomography scan.

SARS‑CoV‑2 belongs to the broad family of viruses known as coronaviruses. It is a positive-sense single-stranded RNA (+ssRNA) virus, with a single linear RNA segment. Coronaviruses infect humans, other mammals, including livestock and companion animals, and avian species. Human coronaviruses are capable of causing illnesses ranging from the common cold to more severe diseases such as Middle East respiratory syndrome (MERS, fatality rate ~34%). SARS-CoV-2 is the seventh known coronavirus to infect people, after 229E, NL63, OC43, HKU1, MERS-CoV, and the original SARS-CoV.

Like the SARS-related coronavirus implicated in the 2003 SARS outbreak, SARS‑CoV‑2 is a member of the subgenus Sarbecovirus (beta-CoV lineage B). Coronaviruses undergo frequent recombination. The mechanism of recombination in unsegmented RNA viruses such as SARS-CoV-2 is generally by copy-choice replication, in which gene material switches from one RNA template molecule to another during replication. The SARS-CoV-2 RNA sequence is approximately 30,000 bases in length, relatively long for a coronavirus—which in turn carry the largest genomes among all RNA families. Its genome consists nearly entirely of protein-coding sequences, a trait shared with other coronaviruses. (Full article)

Disease progress

As of 2 June 2024, 775,522,390 casesofCOVID-19 have been reported, resulting in 7,049,617 reported deaths.^[1]

[expand]

[collapse]

Updated June 2, 2024.

COVID-19 pandemicbylocation^[1]
	Location	Cases	Deaths
	World^[a]	775,522,390	7,049,617
	European Union^[b]	185,641,885	1,261,443
	United States	103,436,829	1,187,771
	China^[c]	99,357,895	122,215
	India	45,039,140	533,610
	France	38,997,490	168,091
	Germany	38,437,756	174,979
	Brazil	37,519,960	702,116
	South Korea	34,571,873	35,934
	Japan	33,803,572	74,694
	Italy	26,722,730	197,018
	United Kingdom	24,929,992	232,112
	Russia	24,180,909	402,878
	Turkey	17,004,714	101,419
	Spain	13,980,340	121,852
	Australia	11,861,161	25,236
	Vietnam	11,624,000	43,206
	Argentina	10,132,025	130,860
	Taiwan	9,970,937	17,672
	Netherlands	8,636,374	22,986
	Mexico	7,709,747	335,011
	Iran	7,627,863	146,837
	Indonesia	6,829,029	162,058
	Poland	6,662,888	120,711
	Colombia	6,385,568	142,727
	Austria	6,082,348	22,534
	Portugal	5,644,144	28,160
	Greece	5,634,857	39,013
	Ukraine	5,531,685	109,920
	Chile	5,400,274	62,705
	Malaysia	5,283,624	37,350
	Belgium	4,862,069	34,339
	Israel	4,841,558	12,707
	Canada	4,810,303	55,057
	Thailand	4,779,858	34,641
	Czech Republic	4,759,418	43,503
	Peru	4,524,748	220,831
	Switzerland	4,453,957	14,188
	Philippines	4,140,383	66,864
	South Africa	4,072,697	102,595
	Romania	3,528,866	68,803
	Denmark	3,435,018	9,667
	Singapore	3,006,155	2,024
	Hong Kong	2,876,106	13,466
	Sweden	2,752,044	27,294
	New Zealand	2,593,269	4,008
	Serbia	2,583,470	18,057
	Iraq	2,465,545	25,375
	Hungary	2,230,419	49,051
	Bangladesh	2,050,243	29,495
	Slovakia	1,877,753	21,226
	Georgia	1,862,754	17,150
	Jordan	1,746,997	14,122
	Republic of Ireland	1,736,596	9,613
	Pakistan	1,580,631	30,656
	Norway	1,507,772	5,732
	Kazakhstan	1,504,370	19,072
	Finland	1,499,712	11,466
	Lithuania	1,366,434	9,805
	Slovenia	1,355,911	10,056
	Bulgaria	1,329,313	38,700
	Croatia	1,317,083	18,752
	Morocco	1,279,115	16,305
	Puerto Rico	1,252,713	5,938
	Guatemala	1,250,358	20,216
	Lebanon	1,239,904	10,947
	Costa Rica	1,230,653	9,368
	Bolivia	1,212,131	22,387
	Tunisia	1,153,361	29,423
	Cuba	1,113,662	8,530
	Ecuador	1,076,184	36,049
	United Arab Emirates	1,067,030	2,349
	Panama	1,044,357	8,706
	Uruguay	1,041,229	7,664
	Mongolia	1,011,478	2,136
	Nepal	1,003,450	12,031
	Belarus	994,037	7,118
	Latvia	977,765	7,475
	Saudi Arabia	841,469	9,646
	Azerbaijan	835,410	10,353
	Paraguay	735,759	19,880
	Palestine	703,228	5,708
	Bahrain	696,614	1,536
	Cyprus	691,247	1,445
	Sri Lanka	672,763	16,901
	Kuwait	667,290	2,570
	Dominican Republic	661,103	4,384
	Myanmar	642,339	19,494
	Moldova	635,666	12,237
	Estonia	610,427	2,998
	Venezuela	552,695	5,856
	Egypt	516,023	24,830
	Qatar	514,524	690
	Libya	507,269	6,437
	Ethiopia	501,170	7,574
	Réunion	494,595	921
	Honduras	472,791	11,114
	Armenia	451,831	8,777
	Bosnia and Herzegovina	403,643	16,388
	Oman	399,449	4,628
	Luxembourg	391,429	1,000
	North Macedonia	350,591	9,977
	Zambia	349,644	4,069
	Brunei	344,320	178
	Kenya	344,101	5,689
	Albania	334,863	3,605
	Botswana	330,650	2,801
	Mauritius	327,305	1,070
	Kosovo	274,279	3,212
	Algeria	272,028	6,881
	Nigeria	267,188	3,155
	Zimbabwe	266,362	5,740
	Montenegro	251,280	2,654
	Afghanistan	235,214	7,998
	Mozambique	233,808	2,252
	Martinique	230,354	1,104
	Laos	219,043	671
	Iceland	209,964	186
	Guadeloupe	203,235	1,021
	El Salvador	201,866	4,230
	Trinidad and Tobago	191,496	4,390
	Maldives	186,694	316
	Uzbekistan	175,081	1,016
	Namibia	172,408	4,108
	Uganda	172,149	3,632
	Ghana	172,023	1,462
	Jamaica	156,833	3,600
	Cambodia	139,127	3,056
	Rwanda	133,249	1,468
	Cameroon	125,217	1,974
	Malta	121,454	906
	Barbados	110,680	593
	Angola	107,451	1,937
	Democratic Republic of the Congo	100,615	1,470
	French Guiana	98,041	413
	Malawi	89,168	2,686
	Senegal	89,078	1,971
	Kyrgyzstan	88,953	1,024
	Ivory Coast	88,425	835
	Suriname	82,496	1,405
	New Caledonia	80,163	314
	French Polynesia	79,302	650
	Eswatini	75,356	1,427
	Guyana	74,126	1,301
	Belize	71,409	688
	Fiji	69,047	885
	Madagascar	68,535	1,427
	Jersey	66,391	161
	Cabo Verde	64,474	417
	Sudan	63,993	5,046
	Mauritania	63,864	997
	Bhutan	62,697	21
	Syria	57,423	3,163
	Burundi	54,569	15
	Guam	52,287	419
	Seychelles	51,695	172
	Gabon	49,051	307
	Andorra	48,015	159
	Papua New Guinea	46,864	670
	Curaçao	45,883	305
	Aruba	44,224	292
	Tanzania	43,226	846
	Mayotte	42,027	187
	Togo	39,530	290
	Bahamas	38,577	848
	Guinea	38,572	468
	Isle of Man	38,008	116
	Lesotho	36,138	709
	Guernsey	35,326	67
	Faroe Islands	34,658	28
	Haiti	34,298	860
	Mali	33,164	743
	Cayman Islands	31,472	37
	Saint Lucia	30,252	410
	Benin	28,036	163
	Somalia	27,334	1,361
	Federated States of Micronesia	26,547	65
	Solomon Islands	25,954	199
	United States Virgin Islands	25,389	132
	San Marino	25,292	126
	Republic of the Congo	25,219	389
	Timor-Leste	23,460	138
	Burkina Faso	22,126	400
	Liechtenstein	21,576	89
	Gibraltar	20,550	113
	Grenada	19,693	238
	Bermuda	18,860	165
	South Sudan	18,823	147
	Tajikistan	17,786	125
	Monaco	17,181	67
	Equatorial Guinea	17,130	183
	Samoa	17,057	31
	Tonga	16,958	12
	Marshall Islands	16,178	17
	Nicaragua	16,146	245
	Dominica	16,047	74
	Djibouti	15,690	189
	Central African Republic	15,440	113
	Northern Mariana Islands	14,689	41
	Gambia	12,627	372
	Collectivity of Saint Martin	12,324	46
	Vanuatu	12,019	14
	Greenland	11,971	21
	Yemen	11,945	2,159
	Caribbean Netherlands	11,922	41
	Sint Maarten	11,051	92
	Eritrea	10,189	103
	Saint Vincent and the Grenadines	9,674	124
	Guinea-Bissau	9,614	177
	Niger	9,515	315
	Comoros	9,109	160
	Antigua and Barbuda	9,106	146
	American Samoa	8,359	34
	Liberia	7,930	294
	Sierra Leone	7,836	125
	Chad	7,702	194
	British Virgin Islands	7,459	64
	Cook Islands	7,326	2
	Sao Tome and Principe	6,771	80
	Turks and Caicos Islands	6,754	40
	Saint Kitts and Nevis	6,607	46
	Palau	6,332	10
	Saint Barthélemy	5,507	5
	Nauru	5,393	1
	Kiribati	5,085	24
	Anguilla	3,904	12
	Wallis and Futuna	3,760	9
	Macau	3,514	121
	Saint Pierre and Miquelon	3,426	2
	Tuvalu	2,943	1
	Saint Helena, Ascension and Tristan da Cunha	2,166	—
	Falkland Islands	1,923	—
	Montserrat	1,403	8
	Niue	1,074	—
	Tokelau	80	0
	Vatican City	26	0
	Pitcairn Islands	4	—
	North Korea	1	6
	Turkmenistan	0	0
^ Countries which do not report data for a column are not included in that column's world total. ^ Data on member states of the European Union are individually listed, but are also summed here for convenience. They are not double-counted in world totals. ^ Does not include special administrative regions (Hong Kong and Macau) or Taiwan.

(Full article)

About the symptoms

Symptoms of coronavirus disease 2019 (COVID-19)

The symptomsofCOVID-19 are variable depending on the type of variant contracted, ranging from mild symptoms to a potentially fatal illness. Common symptoms include coughing, fever, loss of smell (anosmia) and taste (ageusia), with less common ones including headaches, nasal congestion and runny nose, muscle pain, sore throat, diarrhea, eye irritation, and toes swelling or turning purple, and in moderate to severe cases, breathing difficulties. People with the COVID-19 infection may have different symptoms, and their symptoms may change over time. Three common clusters of symptoms have been identified: one respiratory symptom cluster with cough, sputum, shortness of breath, and fever; a musculoskeletal symptom cluster with muscle and joint pain, headache, and fatigue; and a cluster of digestive symptoms with abdominal pain, vomiting, and diarrhea. In people without prior ear, nose, or throat disorders, loss of taste combined with loss of smell is associated with COVID-19 and is reported in as many as 88% of symptomatic cases. (Full article)

About the spread

COVID-19 is mainly transmitted when people breathe in air contaminated by droplets/aerosols and small airborne particles containing the virus. Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is more likely the closer people are. However, infection can occur over longer distances, particularly indoors.

Infectious particles range in size from aerosols that remain suspended in the air for long periods of time to larger droplets that remain airborne briefly or fall to the ground. Additionally, COVID-19 research has redefined the traditional understanding of how respiratory viruses are transmitted. The largest droplets of respiratory fluid do not travel far, but can be inhaled or land on mucous membranes on the eyes, nose, or mouth to infect. Aerosols are highest in concentration when people are in close proximity, which leads to easier viral transmission when people are physically close, but airborne transmission can occur at longer distances, mainly in locations that are poorly ventilated; in those conditions small particles can remain suspended in the air for minutes to hours. (Full article)

Containment measures

Goals of mitigation include delaying and reducing peak burden on healthcare (flattening the curve) and lessening overall cases and health impact.

Many countries attempted to slow or stop the spread of COVID-19 by recommending, mandating or prohibiting behaviour changes, while others relied primarily on providing information. Measures ranged from public advisories to stringent lockdowns. Outbreak control strategies are divided into elimination and mitigation. Experts differentiate between" zero-COVID", which is an elimination strategy, and mitigation strategies that attempt to lessen the effects of the virus on society, but which still tolerate some level of transmission within the community. Containment strategies consists of the use of public health measures such as contact tracing, mass testing, border quarantine, lockdowns and mitigation software.These strategies can be pursued sequentially or simultaneously during the acquired immunity phase through natural and vaccine-induced immunity.

(Full article)

Videos

Animation describing the structure of a coronavirus

Video about what SARS-CoV-2 does to the human body

Video about the transmission of coronaviruses

(More videos)

Did you know?

... that Potamophylax coronavirus's range has been described as a battlefield between scientists and hydropower plant management?
(More did you know facts)

Data maps

Cases and deaths

Total confirmed cases by reporting area

3,000 + per 100,000 inhabitants

1,000–3,00 per 100,000 inhabitants

300–1,000 per 100,000 inhabitants

100–300 per 100,000 inhabitants

30–100 per 100,000 inhabitants

0–30 per 100,000 inhabitants

None or no data

Total confirmed deaths by country

100+ per 100,000 inhabitants

18–100 per 100,000 inhabitants

3.3–18 per 100,000 inhabitants

0.6–3.3 per 100,000 inhabitants

0.1–0.6 per 100,000 inhabitants

<0.1 per 100,000 inhabitants

None or no data

(More statistics)

Economic impact

The COVID-19 pandemic caused far-reaching economic consequences including the COVID-19 recession, the second largest global recession in recent history, decreased business in the services sector during the COVID-19 lockdowns, the 2020 stock market crash (which included the largest single-week stock market decline since the financial crisis of 2007–2008), the impact of COVID-19 on financial markets, the 2021–2023 global supply chain crisis, the 2021–2023 inflation surge, shortages related to the COVID-19 pandemic including the 2020–present global chip shortage, panic buying, and price gouging. The pandemic led to governments providing an unprecedented amount of stimulus, and was also a factor in the 2021–2022 global energy crisis and 2022–2023 food crises.

Amidst the recovery and containment, the world economic system was characterized as experiencing significant, broad uncertainty. Economic forecasts and consensus among macroeconomics experts show significant disagreement on the overall extent, long-term effects and projected recovery. A large general increase in prices was attributed to the pandemic. In part, the record-high energy prices were driven by a global surge in demand as the world quit the economic recession caused by COVID-19, particularly due to strong energy demand in Asia. (Full article)

Workplace

Hazard controls for COVID-19 in workplaces are the application of occupational safety and health methodologies for hazard controls to the prevention of COVID-19. Vaccination is the most effective way to protect against severe illness or death from COVID-19. Multiple layers of controls are recommended, including measures such as remote work and flextime, increased ventilation, personal protective equipment (PPE) and face coverings, social distancing, and enhanced cleaning programs. (Full article)

Misinformation

False information, including intentional disinformation and conspiracy theories, about the scale of the COVID-19 pandemic and the origin, prevention, diagnosis, and treatment of the disease has been spread through social media, text messaging, and mass media. False information has been propagated by celebrities, politicians, and other prominent public figures. Many countries have passed laws against "fake news", and thousands of people have been arrested for spreading COVID-19 misinformation. The spread of COVID-19 misinformation by governments has also been significant. (Full article)

Testing

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests (serology immunoassays) instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate. (Full article)

Vaccine research

ACOVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).

The COVID‑19 vaccines are widely credited for their role in reducing the spread of COVID‑19 and reducing the severity and death caused by COVID‑19. According to a June 2022 study, COVID‑19 vaccines prevented an additional 14.4 to 19.8 million deaths in 185 countries and territories from 8 December 2020 to 8 December 2021. Many countries implemented phased distribution plans that prioritized those at highest risk of complications, such as the elderly, and those at high risk of exposure and transmission, such as healthcare workers. (Full article)

Drug research

COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19). From early 2020 through 2021, several hundred drug companies, biotechnology firms, university research groups, and health organizations were developing therapeutic candidates for COVID-19 disease in various stages of preclinicalorclinical research (506 total candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as of April 2021. (Full article)

Images

Scanning electron microscope image of SARS-CoV-2 (centre, yellow)

This image reveals ultra-structural morphology exhibited by the virus

SARS-CoV-2 structure

(More images)

Topics

COVID-19 pandemic

SARS-CoV-2 (virus)
COVID-19 (disease)

Timeline

Pre-pandemic

2019
- December
2020
- January
- February
  - responses
- March
  - responses
- April
  - responses
- May
  - responses
- June
  - responses
- July
  - responses
- August
  - responses
- September
  - responses
- October
  - responses

Locations

Africa

Northern	Algeria Canary Islands Ceuta Egypt Libya Mauritania Melilla Morocco Sudan Tunisia Western Sahara Sahrawi Arab Democratic Republic
Eastern	Burundi Comoros Djibouti Eritrea Ethiopia Kenya Madagascar Mauritius Mayotte Réunion Rwanda Seychelles Somalia Puntland Somaliland South Sudan Tanzania Uganda
Southern	Angola Botswana Eswatini Lesotho Malawi Mozambique Namibia South Africa Zambia Zimbabwe
Central	Cameroon Central African Republic Chad Democratic Republic of the Congo Republic of the Congo Gabon São Tomé and Príncipe
Western	Benin Burkina Faso Cape Verde Equatorial Guinea Gambia Ghana timeline Guinea Guinea-Bissau Ivory Coast Liberia Mali Niger Nigeria Senegal Sierra Leone Togo

Asia

Central / North

East

Brunei
Cambodia
East Timor
Indonesia
- timeline
- social restrictions
Laos
Malaysia
- timeline
- movement control order
- Johor
- Kuala Lumpur
- Sabah
- Sarawak
- Selangor
Myanmar
Singapore
- timeline
- circuit breaker response
Thailand
- Nonthaburi
Vietnam

Philippines

West

Europe

United Kingdom	timeline January–June 2020 July–December 2020 government response criticism social impact economic impact education shutdown Operation Rescript England timeline London Northern Ireland timeline Scotland timeline Wales timeline Crown dependencies Isle of Man Jersey Guernsey Overseas territories Akrotiri and Dhekelia Gibraltar response
Eastern	Armenia Azerbaijan Belarus Georgia Kazakhstan Moldova Gagauzia Transnistria Russia timeline government responses Crimea Sevastopol Ukraine Crimea Sevastopol Donetsk Luhansk
Balkans	Albania Bosnia and Herzegovina Montenegro North Macedonia Serbia protests and riots Kosovo Turkey timeline
Microstates	Andorra San Marino Vatican City Monaco
European Union EFTA countries	Austria Belgium Bulgaria Croatia timeline Cyprus Northern Cyprus Czech Republic Denmark Faroe Islands Estonia Finland Åland France Guadeloupe French Guiana Réunion Martinique Mayotte Saint Martin Germany North Rhine-Westphalia Greece Hungary Iceland Ireland timeline social impact Italy lockdown Latvia Liechtenstein Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania timeline Slovakia Slovenia Spain timeline Asturias Canary Islands Ceuta Community of Madrid Melilla Sweden timeline government response Switzerland

North America

Mexico	timeline
Central America	Belize Costa Rica El Salvador Guatemala Honduras Nicaragua Panama
Canada	timeline economic impact Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Peel Region Toronto Prince Edward Island Quebec Montreal Saskatchewan Yukon
Caribbean	Antigua and Barbuda Bahamas Barbados British Overseas Territories Anguilla British Virgin Islands Cayman Islands Montserrat Turks and Caicos Islands response Cuba Guantanamo Bay Naval Base Dominica Dominican Republic Dutch Caribbean Aruba Curaçao Sint Maarten Caribbean Netherlands Bonaire Saba Sint Eustatius French West Indies Guadeloupe Martinique Saint Barthélemy Saint Martin Grenada Haiti Jamaica Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Trinidad and Tobago US insular areas Puerto Rico U.S. Virgin Islands
United States	timeline social impact economic impact federal government response state and local government responses Regional responses Eastern States Multi-state Council Midwest Governors Regional Pact Western States Pact Trump administration communication Alabama Alaska Arizona Navajo Nation Arkansas California S.F. Bay Area Colorado Connecticut Delaware Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts timeline Boston timeline Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York New York City North Carolina North Dakota Northern Mariana Islands Ohio impact Columbus Oklahoma Oregon Portland Pennsylvania Philadelphia Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas U.S. Virgin Islands Utah Vermont Virginia Washington Washington, D.C. White House West Virginia Wisconsin statistics Wyoming
Atlantic	Bermuda Greenland Saint Pierre and Miquelon

Oceania

South America

Other

Impacts

Culture and entertainment	Arts and cultural heritage Cinema films affected Disney Education Fashion industry In popular culture Music industry Performing arts Sports association football cricket disc golf motorsport NBA Television U.S. programs affected Video games
Society and rights	Social social media stigma COVID-19 parties Children foster care in the United States Gender Healthcare workers Hospitals Human rights Legal abortion in the U.S. crime domestic violence prisons U.S. immigration detention LGBT community Long-term care facilities Public transport Religion Catholic Church Hajj Strikes Xenophobia and racism
Economic	Aviation Airlines Cannabis industry Charitable activity COVID-19 recession Financial markets Food industry meat industry in Canada meat industry in the U.S. restaurant industry in the U.S. Global stock market crash Hospitals Oil price war Retail Tourism Travel restrictions
Information	Journalism Media coverage Misinformation Wikipedia's response
Politics	National responses Legislation Protests U.S. International relations Aid European Union
Others	Anthropause Environment Military Science and technology Famine

Health issues

Problems and
restrictions

Prevention

Treatments
and research

Pregnancy
Treatment research
Drug repurposing research
- Dexamethasone
Drug development
Vaccine research
- Sputnik V (Russia)
- CoronaVac
- Operation Warp Speed (U.S.)
- Solidarity trial (WHO)
- RECOVERY Trial (UK)

Institutions

Hospitals and
related

Organizations

Coalition for Epidemic Preparedness Innovations
World Health Organization
United Nations
- resolutions
International Committee on Taxonomy of Viruses
Wuhan Institute of Virology (China)
Central Epidemic Command Center (Taiwan)
Taiwan Centers for Disease Control (Taiwan)
COVID-19 Response Acceleration Task Force (Indonesia)
White House Coronavirus Task Force (United States)
Great American Economic Revival Industry Groups (United States)
Coronavirus Tech Handbook
Inter-Agency Task Force for the Management of Emerging Infectious Diseases (Philippines)
PM CARES Fund (India)
Artist Relief (United States)
Covid Watch
SAARC COVID-19 Emergency Fund (India)
COVID-19 Solidarity Response Fund
MusiCares COVID-19 Relief Fund
Imperial College COVID-19 Response Team (UK)
SAGE (UK)
National Cabinet (Australia)
National COVID-19 Coordination Commission (Australia)
UN COVID-19 Supply Chain Task Force (WHO)
COVID-19 Supply Council (Canada)
PREPARE (European Union)
National Public Health Emergency Team (Ireland)
Africa Centres for Disease Control and Prevention (African Union)
Ghana Infectious Disease Centre (Ghana)
COVID-19 Immunity Task Force (Canada)
Novel Coronavirus Expert Meeting (Japan)
Coronavirus Scientific Advisory Board (Turkey)
Crisis Preparedness and Response Centre (Malaysia)
Korea Disease Control and Prevention Agency (Korea)

People

Medical professionals

Researchers

Officials

WHO

Tedros Adhanom (Director-General of the WHO)
Bruce Aylward (Team lead of WHO-China COVID-19 mission)
Maria Van Kerkhove (Technical Lead for COVID-19 response)
Michael J. Ryan (Executive Director of the WHO Health Emergencies Programme)

Countries

Frank Atherton (Wales)
Scott Atlas (United States)
Deborah Birx (United States)
Ashley Bloomfield (New Zealand)
Angelo Borrelli (Italy)
Catherine Calderwood (Scotland)
Carmen Deseda (Puerto Rico)
Jaap van Dissel (the Netherlands)
Shan-chwen Chang (Taiwan)
Chen Shih-chung (Taiwan)
Chuang Yin-ching (Taiwan)
Francisco Duque (Philippines)
Anthony Fauci (United States)
Ronan Glynn (Ireland)
Jeong Eun-kyeong (South Korea)
Fahrettin Koca (Turkey)
Li Keqiang (China)
Michael McBride (Northern Ireland)
Oriol Mitjà (Andorra)
Doni Monardo (Indonesia)
Noor Hisham Abdullah (Malaysia)
Jérôme Salomon (France)
Fernando Simón (Spain)
Gregor Smith (Scotland)
Ih-Jen Su (Taiwan)
Łukasz Szumowski (Poland)
Anders Tegnell (Sweden)
Theresa Tam (Canada)
Sotiris Tsiodras (Greece)
Chris Whitty (United Kingdom)
Lawrence Wong (Singapore)

Others

Deaths

List

Get involved!

Get involved by joining WikiProject COVID-19. We discuss collaborations and all manner of issues on our talk page. As of 2 June 2024, there are 2,456 articles within the project's scope. A full list is available here.

Related portals

References

^ ^a ^b Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; Macdonald, Bobbie; Beltekian, Diana; Dattani, Saloni; Roser, Max (2020–2022). "Coronavirus Pandemic (COVID-19)". Our World in Data. Retrieved 2024-06-02.